StocksFin Logo
Boston Scientific Corporation country of incorporation
|
|
Mr. Michael Mahoney
|
41,000 employees
NYSE | Healthcare | Medical Devices
HCA Healthcare, Inc. country of incorporation
|
|
Mr. Samuel Hazen
|
204,000 employees
NYSE | Healthcare | Medical Care Facilities
Q322 reported Nov 3, 2022 Reporting Period
$3.17B 8.1% vs. Q321 Revenues Q322
69.12% 0.4% vs. Q321 Gross Profit Margin
5.49% -61.6% vs. Q321 Net Profit Margin
320M -31.2% vs. Q321 Free Cash Flow Q322
$0.12 -57.1% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.03%
Q322
0.3%
Q322 reported Nov 1, 2022 Reporting Period
$14.97B -2% vs. Q321 Revenues Q322
84.5% 0.7% vs. Q321 Gross Profit Margin
7.57% -49% vs. Q321 Net Profit Margin
1.89B -17% vs. Q321 Free Cash Flow Q322
$3.95 -45.4% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.03%
Q322
0.3%
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
0.62
0.98
Current Ratio
1.45
1.38
Cash Ratio
0.1
0.1
Price to Book
3.14
-15.65
Price to Sales
17.49
3.52
Price to Earnings
79.66
11.63